Aoxing Pharmaceutical Company, Inc.  

(Public, NYSEMKT:AXN)   Watch this stock  
Find more results for NYSEAMEX:AXN
0.379
0.000 (0.00%)
Real-time:   4:00PM EDT
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 0.21 - 0.72
Open     -
Vol / Avg. 38.00/29,184.00
Mkt cap 18.91M
P/E     -
Div/yield     -
EPS -0.33
Shares 49.87M
Beta 2.08
Inst. own 0%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -78.23% -159.66%
Operating margin -29.35% -131.32%
EBITD margin - -50.19%
Return on average assets -19.11% -40.77%
Return on average equity -991.35% -121.99%
Employees 589 -
CDP Score - -

Address

Suite 3338, 444 Washington Blvd
JERSEY CITY, NJ 07310
United States - Map
+1-646-3671747 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aoxing Pharmaceutical Company, Inc. (Aoxing Pharma), is a pharmaceutical company, which specializes in research, development, manufacturing and distribution of a variety of narcotics and pain-management products and drug-relief medicine. The Company has one operating subsidiary, Hebei Aoxing Pharmaceutical Co., Inc. (Hebei Aoxing).Hebei Aoxing is engaged in developing narcotics and pain management products. The Company owns 95% of the equity in Hebei Aoxing. The Company's product offerings include Zhongtongan,Bismuth Potassium Citrate,Xiaopiling, and Naloxone Hydrochloride.

Officers and directors

Zhenjiang Yue Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Guoan Zhang Acting Chief Financial Officer, Senior Vice President - Finance
Age: 44
Bio & Compensation  - Reuters
Guirong Zhou President - Research and Development
Age: 60
Bio & Compensation  - Reuters
Jun Min Director
Age: 55
Bio & Compensation  - Reuters
Yang Li Independent Director
Age: 34
Bio & Compensation  - Reuters
Guozhu Xu Independent Director
Age: 68
Bio & Compensation  - Reuters